SANTÉ INVESTS AT THE LEADING EDGE OF INNOVATION IN HEALTHCARE AND TECHNOLOGY. WE MANAGE OVER A HALF-BILLION DOLLARS OF CAPITAL IN TWO SEPARATE STRATEGIES.
Privately Held Companies
Santé Ventures invests in innovative new healthcare companies, with a particular focus in Biotech, Medtech, and Healthtech.
Publicly Traded Securities
Santé Capital applies state-of-the-art data science and machine learning technologies to generate attractive risk-adjusted returns in a systematic liquid strategy.
02 Santé Ventures Strategy
We search the emerging technology landscape for visionary entrepreneurs and innovative new ideas with the potential to deliver better patient health outcomes through advances in biology, medicine, and information.
03 Santé Capital Strategy
We leverage the latest advances in big data, machine learning, and natural language processing to systematically capture investment opportunities in a liquid portfolio of mispriced publicly traded securities.
04 NewsroomSee All News
Santé Ventures Raises $260 Million in Fourth Fund
September 16, 2021
Santé Ventures Names Thomas Krummel, MD, as Venture Partner
April 1, 2021
Cryosa Closes $21.5 Million Series B Funding Round to Advance Minimally Invasive Obstructive Sleep Apnea Treatment
September 23, 2021
BioStable Science & Engineering Initiates European Commercialization of the HAART™ 200 Aortic Annuloplasty Device
August 6, 2021